| Investor Type | Firm |
| Industries | BioTech • A.I. (& Big Data) • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Nanotechnology • Pharmaceutical (& Medicine) • Woman Focused |
| Stages | Pre-Seed, Seed, Series A |
| Investing | United Kingdom • Portugal |
| Investment Range | $200,000 - $1,300,000 |
| Investment Sweet Spot | $750,000 |
Neo Kuma Ventures is an investment firm that specializes in funding early-stage companies in the psychedelic healthcare space. With a focus on clinical research, they aim to advance and redefine the standard of patient care. They target the use of psychedelic therapies to address mental illnesses like depression, anxiety, and addiction, supporting products and therapies recognized by the FDA and the scientific community for their potential to lead to major breakthroughs.
Neo Kuma Ventures offers an average ticket size ranging from £150k to £1m and aims to engage with companies from Pre-Seed to Series A stages. Committed to a global market with a European focus, they invest in diverse categories including compounds, clinics and care delivery, digital therapeutics, and platforms.
They distinguish themselves by being one of the largest European VC funds in this sector, noted for their discipline and diligence. Neo Kuma Ventures is not only an investor but also constructs an ecosystem to support founders from inception to success.
They are associated with significant ventures such as Atai Lifescience, Beckley Psytech, and Kanna Health. They support policy formation through active involvement with partners like Drug Science and the International Therapeutic Psilocybin Rescheduling Initiative. The team includes accomplished professionals like Clara Burtenshaw, Sean McLintock, Fergus Argyle, Dr.
Peter Crane, Dr. Willem Hendrik Gispen, Isabel Fox, Lomax Ward, and Christina Sass, who bring vast experience from various sectors including biotech, pharmaceuticals, neuropharmacology, and venture capital.
Neo Kuma Ventures pursues investments within several industries, such as BioTech, A.I. (& Big Data), HealthTech (& Fitness), Medical Devices (& Hospital Services), Healthcare (& Wellness), Nanotechnology, and Pharmaceutical (& Medicine). They are also attentive to promoting women-focused ventures, manifesting a comprehensive approach to investment that extends beyond pure capital support to include network connections and ecosystem building.
